About
Compounds to induce endogenous oligodendrocyte progenitor cells to remyelinate axons in MS patients
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Funding History (1)
D
May 17, 2024
Locations (1)
Headquarters
Watertown, MA, United States
Map
Loading map...